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Abstract
Hypoplastic left heart syndrome(HLHS) refers to the abnormal development of the left-sided
cardiac structures, resulting in obstruction to blood flow from the left ventricular outflow tract. In
addition, the syndrome includes underdevelopment of the left ventricle, aorta, and aortic arch, as
well as mitral atresia or stenosis. HLHS has been reported to occur in approximately 0.016 to
0.036% of all live births. Newborn infants with the condition generally are born at full term and
initially appear healthy. As the arterial duct closes, the systemic perfusion becomes decreased,
resulting in hypoxemia, acidosis, and shock. Usually, no heart murmur, or a non-specific heart
murmur, may be detected. The second heart sound is loud and single because of aortic atresia.
Often the liver is enlarged secondary to congestive heart failure. The embryologic cause of the
disease, as in the case of most congenital cardiac defects, is not fully known. The most useful
diagnostic modality is the echocardiogram. The syndrome can be diagnosed by fetal
echocardiography between 18 and 22 weeks of gestation. Differential diagnosis includes other left-
sided obstructive lesions where the systemic circulation is dependent on ductal flow (critical aortic
stenosis, coarctation of the aorta, interrupted aortic arch). Children with the syndrome require
surgery as neonates, as they have duct-dependent systemic circulation. Currently, there are two
major modalities, primary cardiac transplantation or a series of staged functionally univentricular
palliations. The treatment chosen is dependent on the preference of the institution, its experience,
and also preference. Although survival following initial surgical intervention has improved
significantly over the last 20 years, significant mortality and morbidity are present for both surgical
strategies. As a result pediatric cardiologists continue to be challenged by discussions with families
regarding initial decision relative to treatment, and long-term prognosis as information on long-
term survival and quality of life for those born with the syndrome is limited.
Disease name and synonyms
The congenital heart lesion more commonly known today
as hypoplastic left heart syndrome (HLHS) was initially
termed hypoplasia of the aortic tract complex by Lev in
1952 [1]. This initial description resulted from examina-
tion of a series of specimens found to have isolated hypo-
plasia of the aorta, hypoplasia of the aorta and ventricular
septal defect, and hypoplasia of the aorta with aortic sten-
osis or atresia, with and without mitral stenosis or atresia.
The series of Lev was followed by the study of Noonan
and Nadas, who in 1958 first used the term hypoplastic
left heart syndrome collectively to describe their series of
specimens with multiple malformations involving left-
sided structures of the heart [2].
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Definition and diagnostic criteria
Hypoplastic left heart syndrome refers to the abnormal
development of the left-sided cardiac structures, resulting
in obstruction to blood flow from the left ventricular out-
flow tract. In addition, the syndrome includes underde-
velopment of the left ventricle, aorta, and aortic arch, as
well as mitral atresia or stenosis. The severity of outflow
obstruction, the left heart structures involved, and the
degree of left ventricular and aortic hypoplasia, may vary
among patients, resulting in a spectrum of patients with
varying levels of severity [3].
Epidemiology
The syndrome has been reported to occur in approxi-
mately 0.016 to 0.036% of all live births [4-7]. It accounts
for 1 to 3.8 % of all congenital cardiac malformations [8].
Up to seven-tenths of cases are reported to occur in males
[4]. The recurrence risk in siblings is 0.5%, with other
forms of congenitally malformed hearts seen in 13.5%
[9].
Clinical description
Newborn infants generally are born at full term, and ini-
tially appear healthy. With closure of the arterial duct, the
systemic perfusion becomes decreased, resulting in
hypoxemia, acidosis, and shock. Usually, no heart mur-
mur, or a non-specific heart murmur, may be detected.
The second heart sound is loud and single because of aor-
tic atresia. Often the liver is enlarged secondary to conges-
tive heart failure.
A small subset of patients have restriction of blood flow
from the left to right atrium because of an inadequate or
absent atrial communication. Such restriction to flow of
blood from the left to right atrium can result in severe left
atrial hypertension, and decreased blood flow into the
right atrium and the dominant right ventricle, resulting in
decreased flows into both the systemic and pulmonary
circulations. These patients present with cardiogenic
shock and profound cyanosis at birth, and are likely die in
the absence of an intervention, such as catheter-based or
surgical septostomy, performed soon after birth, to relieve
obstruction or to create a means of communication in the
atrial septum, allowing decompression of the left atrium
and free flow of blood from the left atrium into the right
atrium.
Etiology
The embryologic cause, as in the case of most congenitally
malformed hearts, is not fully known. Early epidemio-
logic studies report a multifactorial influence to be the
cause of up to 90% of cardiac anomalies, with a recurrence
rate in further offspring of 2% to 6% [10]. Associated risk
factors include maternal, gestational, and familial condi-
tions. Fetal exposure to teratogens may also be a risk fac-
tor. Likewise, fetal exposure to active maternal infections,
such as rubella, herpesvirus, coxsackievirus B5, and
cytomegalovirus, may be a risk.
Chromosomal aberrations account for about 6% of all
congenitally malformed hearts. Many genetic and heredi-
tary diseases are associated with such congenital malfor-
mations, although the causative mechanism is unknown.
Prospective studies using chromosomal analysis have sug-
gested that some malformations may be the result of a sin-
gle gene defect [11].
In the case of hypoplasia of the left heart, the resulting
multiple anomalies may result from either the multifacto-
rial factors described above, or from a reduction of left
ventricular inflow or outflow during fetal development.
Diagnostic methods
The most useful diagnostic modality is the echocardio-
gram, which may help confirm the diagnosis, and as well
as diagnose basic variability in anatomic structures within
this anatomically heterogenous population. Information
collected should include the size of the inter-atrial com-
munication, function of the atrioventricular valve, and the
size of the ascending aorta, as these are useful measure-
ments for stratifying the options for treatment. Although
the electrocardiogram is non-specific, many patients dis-
play right ventricular hypertrophy, and have paucity of
left ventricular forces. Chest radiographs are not diagnos-
tic, and cardiac catheterization is only needed if an inter-
vention such as creation or enlargement of the inter-atrial
communication is required [12].
Differential diagnosis
The clinical presentation may resemble those of neonates
with other left-sided obstructive lesions where the sys-
temic circulation is dependent on ductal flow. These con-
ditions may include critical aortic stenosis, coarctation of
the aorta, interrupted aortic arch. As with hypoplasia of
the left heart, their clinical presentation is cardiogenic
shock following closure of the arterial duct. Other non-
structural cardiac diseases, with clinical presentation in a
shock-like state, such as neonatal myocarditis and neona-
tal sepsis, should also be included in the differential diag-
nosis. These conditions can be easily differentiated by
echocardiography.
Genetic counseling
Upon diagnosis, both genetic counseling and testing
should be offered to both parents. Multiple genetic syn-
dromes have been reported, including Turner's syndrome,
Noonan's syndrome, Smith-Lemli-Opitz syndrome, Holt-
Oram syndrome, and many others [13,14]. Overall, one-
quarter of all patients have an associated genetic disorder
or major extracardiac abnormality.Orphanet Journal of Rare Diseases 2007, 2:23 http://www.OJRD.com/content/2/1/23
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Antenatal diagnosis
The syndrome can be diagnosed by fetal echocardiogra-
phy between 18 and 22 weeks of gestation [14-16]. Fur-
ther evaluation should include genetic testing, and the
examination for other extracardiac malformations. Once
the diagnosis is made, the perinatal team should monitor
growth and development of the other fetal organs. Vaginal
delivery is often recommended, as long as the fetus has no
signs of cardiac failure. Although the syndrome has not
been found to have deleterious effects on labor and deliv-
ery, most health care professionals advise that the birth of
the infant should occur in a cardiac surgical center.
Management including treatment
Afflicted children require surgery as neonates, as they have
duct-dependent systemic circulation. Currently, there are
two major treatment modalities. These are primary car-
diac transplantation, or a series of staged functionally uni-
ventricular palliations [17]. The functionally
univentricular palliation typically includes three opera-
tions. The first stage of palliation, or the Norwood opera-
tion, is performed at birth. The second stage is a bi-
directional Glenn operation, usually undertaken at 6 to 8
months of age. The third, and final, stage is the Fontan
operation, which can be performed between the ages of
18 months and 4 years. The treatment chosen is depend-
ent on the preference of the institution, its experience, and
also preference. Connor et al., recently evaluated out-
comes for 251 children during 1997, with 17 managed by
primary cardiac transplantation, and 234 by stages pallia-
tion, and showed that death occurred more frequently in
those undergoing primary cardiac transplantation, with
42% dying, compared with those undergoing the Nor-
wood operation, of whom 35% died [18]. The mortality
rate for children managed through primary cardiac trans-
plantation does not include children who died waiting
prior to cardiac transplantation. The increased risk of
death in children waiting for transplantation, and the
scarcity of donor organs during the neonatal period, has
made this modality less favorable, but is still offered in a
few centers in the United States of America [19].
For patients undergoing functionally univentricular palli-
ation, leading to creation of the Fontan circulation, the
highest risk of mortality is following the initial operation,
with up to three-tenths of patients dying in some reported
series [20]. The Norwood operation consists of construct-
ing a new aortic root and arch, disconnecting the pulmo-
nary trunk from the pulmonary circulation, and
incorporating it into the systemic outflow tract. A modi-
fied Blalock-Taussig shunt, of 3 to 4 millimeters in diam-
eter, is constructed to supply blood to the lungs. As
pulmonary vascular resistance is lower than systemic vas-
cular resistance, blood flows from the aortic root to the
pulmonary circulation during diastole. This results in
decreased diastolic blood pressure in the aortic root, and
thus decreased coronary arterial perfusion. As a result,
these children may suffer from myocardial ischemia, caus-
ing cardiac failure and sudden death after discharge from
hospital following successful initial surgical palliation.
Since blood flows into the pulmonary circulation in dias-
tole, the fraction of cardiac output distributed to the pul-
monary circulation is higher than the systemic circulation,
and the blood returning from the pulmonary circulation
creates a volume load to the dominant right ventricle [21].
Recent modifications of the Norwood operation, involv-
ing replacement of the systemic-to-pulmonary arterial
shunt with placement of a cyro-preserved non-valved con-
duit directly from the right ventricle to pulmonary arter-
ies, have resulted in better maintenance of diastolic blood
pressure, and in some centers have improved both hospi-
tal mortality and mortality after discharge for children
undergoing the initial stage of palliation [22]. The advan-
tage of placement of a conduit, however, has still to be
proven in a randomized control trial.
The second stage of palliation is called the bi-directional
Glenn operation. This consists of anastomosis of the supe-
rior caval vein to the right pulmonary artery, and take-
down of the systemic-to-pulmonary arterial shunt or
conduit [23]. Results following the venous shunt are very
good, and the overall operative mortality is reported to be
from 2 to 5.4%. The third stage of palliation is construc-
tion of the Fontan circulation, which consists of routing
the inferior caval venous blood through a conduit placed
in the lateral wall of the right atrium into the pulmonary
arteries, or through an extracardiac conduit. A fenestration
is usually created between the medial wall of the baffle
and the systemic atrium to allow decompression of the
atrial conduit pathway into the systemic atrium. The fen-
estration is usually closed in the catheterization labora-
tory up to 1 or 2 years after the Fontan operation.
Nowadays, the operative mortality for conversion to the
Fontan circulation is also less than 5%. Cardiac catheteri-
zation is usually undertaken prior to both the second and
third stages of palliation to study anatomical and physio-
logical details, and to perform corrective interventions.
Long-term and functional outcome data following the
functionally univentricular palliation is currently being
evaluated.
Unresolved questions
A number of unresolved questions continue to surround
management and treatment [24]. Despite advances in sur-
gical techniques and medical therapies, those with the
syndrome continue to have the highest mortality of all
congenital cardiac malformations for infants less than one
year of age [25], rivaling in this regard those with pulmo-
nary atresia and intact ventricular septum, and those with
isomerism of the right atrial appendages, or asplenia syn-Orphanet Journal of Rare Diseases 2007, 2:23 http://www.OJRD.com/content/2/1/23
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drome. Although survival following initial surgical inter-
vention has improved over the last 20 years, pediatric
cardiologists continue to be challenged by discussions
with families regarding initial decision relative to treat-
ment, and long-term prognosis [26-28]. This is due in part
to the limited information available in short-term and
long-term functional and cognitive behavior in these chil-
dren. The information that is available suggests that,
regardless of surgical approach, staged surgical reconstruc-
tion or transplantation, long-term functional and cogni-
tive behavior is strongly related to initial condition at
diagnosis, and hence is variable [29-31]. Prenatal diagno-
sis, fetal intervention, and its impact on survival after the
first stage of palliation, are areas of current study [32-34].
The limited information available has suggested that
infants diagnosed during the prenatal period are more
likely to survive the initial stage of palliation as compared
to those that are not diagnosed during the prenatal period
[35]. Small controlled clinical studies are investigating
intervention in the fetal period to prevent the develop-
ment of the syndrome through the use of balloon dilation
and placement of stents in areas of restriction or hypopla-
sia. Short-term outcomes for this prenatal intervention are
variable, and continue to be studied [36,37].
Another ongoing discussion, less in the United States of
America than in Europe, involves the option of no inter-
vention, known as compassionate care, and otherwise
described as passive euthanasia. Until 1980, when the
Norwood procedure was introduced, compassionate care
was the only option available to infants born with the syn-
drome. Recent studies seem to suggest most diagnosed
infants now initially undergo a surgical intervention, but
it is not clear if the option of lack of intervention is dis-
cussed with families at the time of initial pre- or postnatal
diagnosis [38-49].
Psycho social concerns
Comprehensive counseling by the health care team is a
critical component of care for the family of a child born
with hypoplastic left heart syndrome. A review of the cur-
rent outcomes of surgical intervention, as well as studies
describing neurological and developmental outcomes,
will guide families in their choice of treatment, or lack of
treatment. For families who elect to have surgical inter-
vention, care for their afflicted child is associated with
numerous hospitalizations, services of a multidisciplinary
team of specialists, and use of both advanced and innova-
tive technology. The significant financial burden, or out of
pocket expenses, that the family will incur should also be
part of the preparation. Additional outside support can be
provided by directing families to support groups available
for families who have a child with congenital cardiac dis-
ease, and other online resources.
Conclusion
As a result of advanced technology, refined surgical tech-
niques, and catheter-based interventions, the mortality in
the short term has improved dramatically for children
born with hypoplasia of the left heart. The syndrome,
nonetheless, it is still considered one of the most complex
congenital cardiac malformations to manage. Many unre-
solved questions regarding treatment, and long-term
functional and cognitive outcomes, remain for these chil-
dren. Further information on these topics is required
appropriately to guide discussions with families regarding
initial options for treatment, long-term survival, and qual-
ity of life.
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